Trial Type and Time to Enrolling First Patient Linked to Slow Patient Accrual in Cancer Clinical Trials

​PHILADELPHIA — Cancer clinical trials initiated through national cooperative groups, and the time taken from trial activation to first patient enrollment, were among the factors associated with slow accrual, according to a study published in Clinical Cancer Research, a journal of the American Association for Cancer Research.

“Clinical trials are the gold standard for evaluating treatments and for new drug approval; however, conducting a clinical trial is a very costly process, so it is important to ensure that the effort is successful,” said J. Jack Lee, PhD, DDS, associate vice provost of quantitative research and professor of biostatistics at The University of Texas MD Anderson Cancer Center in Houston, Texas.

Read Full Article Here >>